93 related articles for article (PubMed ID: 77256)
1. [Clinical experiences with a 6% hydroxyethyl starch 40000 solution; metabolic parameters and tolerance].
Kori-Lindner C; Hubert H
Infusionsther Klin Ernahr; 1978 Apr; 5(2):93-8. PubMed ID: 77256
[TBL] [Abstract][Full Text] [Related]
2. Changes in acid-base, electrolyte and hemoglobin concentrations during infusion of hydroxyethyl starch 130/0.42/6 : 1 in normal saline or in balanced electrolyte solution in children.
Sümpelmann R; Witt L; Brütt M; Osterkorn D; Koppert W; Osthaus WA
Paediatr Anaesth; 2010 Jan; 20(1):100-4. PubMed ID: 19968805
[TBL] [Abstract][Full Text] [Related]
3. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions].
Kröll W; Pölz W; Colombo T; Steindorfer P
Wien Klin Wochenschr; 1994; 106(13):416-21. PubMed ID: 7522379
[TBL] [Abstract][Full Text] [Related]
4. [Hydroxy-ethyl-starch as plasma substitute in transurethral prostatectomy with the "cold-punch" method (author's transl)].
Homann B; Pesold R; Bülow H; Rietbrock I; Hess J; Weis KH
Anaesthesist; 1977 Jan; 26(1):5-10. PubMed ID: 65133
[TBL] [Abstract][Full Text] [Related]
5. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics.
Treib J; Haass A; Pindur G; Seyfert UT; Treib W; Grauer MT; Jung F; Wenzel E; Schimrigk K
Thromb Haemost; 1995 Dec; 74(6):1452-6. PubMed ID: 8772219
[TBL] [Abstract][Full Text] [Related]
6. [Animal experimental studies on the volume expanding effect of hydroxyethyl starch 40000 in the dog acute hemorrhagic shock].
Hartung HJ; Klose R; Lutz H
Infusionsther Klin Ernahr; 1979 Aug; 6(4):231-4. PubMed ID: 90651
[TBL] [Abstract][Full Text] [Related]
7. [Blood volume replacement and hemodilution with hydroxyethyl starch].
Messmer K; Jesch F
Infusionsther Klin Ernahr; 1978 Jun; 5(3):169-77. PubMed ID: 78893
[TBL] [Abstract][Full Text] [Related]
8. [The influence of hydroxyethyl starch solutions on circulation and on kidney function in hypovolaemic patients (author's transl)].
Hempel V; Metzger G; Unseld H; Schorer R
Anaesthesist; 1975 May; 24(5):198-201. PubMed ID: 56899
[TBL] [Abstract][Full Text] [Related]
9. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
[TBL] [Abstract][Full Text] [Related]
10. [Polish hydroxyethyl starch preparation: a clinical study].
Schier J; Kościelak J; Szczepanik A; Gryszkiewicz A; Lopaciuk S; Konopka L; Rudowski W
Acta Haematol Pol; 1979; 10(1):51-8. PubMed ID: 86269
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of 6% and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients.
Friedman G; Jankowski S; Shahla M; Gomez J; Vincent JL
J Clin Anesth; 2008 Nov; 20(7):528-33. PubMed ID: 19019650
[TBL] [Abstract][Full Text] [Related]
12. Alteration of anion gap and strong ion difference caused by hydroxyethyl starch 6% (130/0.42) and gelatin 4% in children.
Witt L; Osthaus WA; Jüttner B; Heimbucher C; Sümpelmann R
Paediatr Anaesth; 2008 Oct; 18(10):934-9. PubMed ID: 18811828
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in 1130 children: results of an European prospective multicenter observational postauthorization safety study (PASS).
Sümpelmann R; Kretz FJ; Luntzer R; de Leeuw TG; Mixa V; Gäbler R; Eich C; Hollmann MW; Osthaus WA
Paediatr Anaesth; 2012 Apr; 22(4):371-8. PubMed ID: 22211931
[TBL] [Abstract][Full Text] [Related]
14. [Hydroxyethyl starch--an interim report].
Weidhase R; Faude K; Weidhase R
Anaesthesiol Reanim; 1998; 23(1):4-14. PubMed ID: 9553245
[TBL] [Abstract][Full Text] [Related]
15. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations.
London MJ; Ho JS; Triedman JK; Verrier ED; Levin J; Merrick SH; Hanley FL; Browner WS; Mangano DT
J Thorac Cardiovasc Surg; 1989 May; 97(5):785-97. PubMed ID: 2468978
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of volume substitutes 5 percent human albumin and 6 percent hydroxyethyl starch (40,000/0.5) in pediatric anesthesia].
Hausdörfer J; Hagemann H; Heine J
Anasth Intensivther Notfallmed; 1986 Jun; 21(3):137-42. PubMed ID: 2428266
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in children: preliminary results of a European Prospective Multicenter Observational Postauthorization Safety Study (PASS).
Sümpelmann R; Kretz FJ; Gäbler R; Luntzer R; Baroncini S; Osterkorn D; Haeger MC; Osthaus WA
Paediatr Anaesth; 2008 Oct; 18(10):929-33. PubMed ID: 18647272
[TBL] [Abstract][Full Text] [Related]
18. Coagulation and biochemical effects of balanced salt-based high molecular weight vs saline-based low molecular weight hydroxyethyl starch solutions during the anhepatic period of liver transplantation.
Ahn HJ; Yang M; Gwak MS; Koo MS; Bang SR; Kim GS; Lee SK
Anaesthesia; 2008 Mar; 63(3):235-42. PubMed ID: 18289228
[TBL] [Abstract][Full Text] [Related]
19. [Hydroxyethyl starch as plasma substitute: experiments in isovolamic haemodilution (author's transl)].
Jesch F; Klövekorn WP; Sunder-Plassmann L; Seifert J; Messmer K
Anaesthesist; 1975 May; 24(5):202-9. PubMed ID: 56900
[TBL] [Abstract][Full Text] [Related]
20. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial.
Godet G; Lehot JJ; Janvier G; Steib A; De Castro V; Coriat P
Eur J Anaesthesiol; 2008 Dec; 25(12):986-94. PubMed ID: 18492315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
